Publication

Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.

Journal Paper/Review - May 8, 2024

Units
PubMed
Doi
Contact

Citation
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie S, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford C, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino M, Witte T, Neumann T, Holle J, Schoenau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos A, Voskuyl A, Daikeler T, Berger C, Molloy E, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel P, Cid M, González-Gay M, Morgan A, Martin-Broto J, Márquez A, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. Lancet Rheumatol 2024; 6:e374-e383.
Type
Journal Paper/Review (English)
Journal
Lancet Rheumatol 2024; 6
Publication Date
May 8, 2024
Issn Electronic
2665-9913
Pages
e374-e383
Brief description/objective

Giant cell arteritis is an age-related vasculitis that mainly affects the aorta and its branches in individuals aged 50 years and older. Current options for diagnosis and treatment are scarce, highlighting the need to better understand its underlying pathogenesis. Genome-wide association studies (GWAS) have emerged as a powerful tool for unravelling the pathogenic mechanisms involved in complex diseases. We aimed to characterise the genetic basis of giant cell arteritis by performing the largest GWAS of this vasculitis to date and to assess the functional consequences and clinical implications of identified risk loci.